Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Satisfaction and Effectiveness of Lurasidone on Quality of Life and Functioning in Adult Patients With Schizophrenia Treated in the Real World Italian Clinical Practice

NCT06527885 is registered in ClinicalTrials.gov with Aziende Chimiche Riunite Angelini Francesco S.p.A as lead sponsor.

NCT NCT06527885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06527885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Satisfaction and Effectiveness of Lurasidone on Quality of Life and Functioning in Adult Patients With Schizophrenia Treated in the Real World Italian Clinical Practice
Lead sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase
Observational
Overall status
Completed
Start date
October 21, 2022
Completion date
September 12, 2023
Enrollment
61 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia